In conclusion, we have successfully identified a novel germline heterozygous, likely pathogenic variant of BRCA2: c.7007G>T (p.R2336L) in a Chinese family with breast cancer by NGS‐based genetic diagnosis, enriching its known mutation spectrum. This evidence concerns the gene BRCA2 and breast carcinoma.